Why did Embecta (EMBC) stock move recently?

On 9/2/2026, Embecta moved +8.4% — No specific catalyst identified in recent filings or credible coverage for the Sept 2 move; EMBC rose amid ongoing positive sentiment from Q3 results (raised FY2026 margin/EPS guidance) and a late-Aug Seeking Alpha turnaround note, with possible momentum from upcoming investor conferences. This is MarketChacha's decoded reason from filings and credible news; it is education, not buy/sell advice.

Is Embecta (EMBC) overvalued or fairly valued?

MarketChacha shows Embecta's valuation in context — a trailing P/E of about 3.2, a forward P/E of about 3.3 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

Does Embecta's reported profit turn into cash?

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash. MarketChacha computes this cash-conversion check (1.21×) from reported figures — education, not a rating.

What is Embecta's revenue?

Embecta reported revenue of $1.1B for FY2025, with net profit of $95.4M, per official filings.

What is the share price of Embecta (EMBC)?

Embecta last traded at $5.80 (+1.9% on the day), as of 9/4/2026 — a delayed quote shown for education, not investment advice.

Embecta

EMBC · NYSE · Healthcare · United States

Snapshot

TickerEMBC

ExchangeNYSE

SectorHealthcare

IndustryMedical Instruments & Supplies

CountryUnited States

Employees1,850

HeadquartersParsippany, United States

Websitewww.embecta.com

Filings tracked15

About Embecta

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Who owns it

Insiders2.0%
Institutions92.4%
Public & other5.6%

438 institutional holders

Ownership breakdown from public market data.

Top holders

Blackrock Inc.8.12%
Yacktman Asset Management Lp7.62%
Vanguard Capital Management LLC4.51%
Deerfield Management Company, L.P4.47%
Jefferies Financial Group Inc.4.16%
Ameriprise Financial, Inc.3.60%
Morgan Stanley3.52%
State Street Corporation2.84%

Largest institutional holders — last updated 6/30/2026.

Forensic scorecard

No major accounting red flags in the fundamentals we have — profit is backed by cash and returns look healthy.

Cash conversion1.21×

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash.

Net margin trend6.3% → 8.8%

Margin has expanded by about 2.5 points — the business is getting more profitable.

Growth qualityrev -2% · PAT 16%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $268.0M · EPS 0.49

Est. earnings growth -30.5%

Next fiscal year

Rev $1.1B · EPS 1.76

Est. earnings growth -4.0%

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Revenue (FY2025)

$1.1B

Net margin

8.8%

Revenue CAGR (2y)

-1.8%

Profit CAGR (2y)

+16.4%

EPS (FY2025)

1.62

Net profit (FY2025)

$95.4M

Ask MarketChacha about EMBC

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Why it moved

Sep 2, 2026
No specific catalyst identified in recent filings or credible coverage for the Sept 2 move; EMBC rose amid ongoing positive sentiment from Q3 results (raised FY2026 margin/EPS guidance) and a late-Aug Seeking Alpha turnaround note, with possible momentum from upcoming investor conferences.
source 1 ↗source 2 ↗· confidence: low
Jul 28, 2026
EMBC rose in a technical rebound from recent lows near its 52-week bottom, with no new operating catalyst; coverage focused on ongoing securities class-action lawsuit notices tied to a prior sharp decline.
source 1 ↗· confidence: low
Jul 22, 2026
No clear company-specific catalyst identified for the decline; the stock appears to have moved lower amid ongoing negative sentiment from securities class action litigation headlines and a 'Strong Sell' analyst consensus.
source 1 ↗source 2 ↗source 3 ↗· confidence: low

Daily moves with the verified reason behind them. Education only — not investment advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin
FY2025	$1.1B	$95.4M	1.62	8.8%
FY2024	$1.1B	$78.3M	1.34	7.0%
FY2023	$1.1B	$70.4M	1.22	6.3%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q2	$271.7M	$21.1M	0.36	7.8%
2026Q1	$221.8M	$-4.1M	-0.07	-1.8%
2025Q4	$261.2M	$44.1M	0.74	16.9%
2025Q2	$295.5M	$45.5M	0.78	15.4%
2025Q1	$259.0M	$23.5M	0.40	9.1%
2024Q4	$261.9M	$0	0.00	0.0%
2024Q2	$272.5M	$14.7M	0.25	5.4%
2024Q1	$287.2M	$28.9M	0.50	10.1%
2023Q4	$277.3M	$20.1M	0.35	7.2%
2023Q2	$286.1M	$15.2M	0.26	5.3%
2023Q1	$277.1M	$14.0M	0.24	5.1%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

10-Q filing
SEC8/7/2026
8-K — Results of operations, Exhibits
SEC8/7/2026material
8-K/A — Exhibits
SEC7/31/2026
8-K — Completion of acquisition/disposition, Reg FD disclosure, Exhibits
SEC5/15/2026material
8-K — Results of operations, Exhibits
SEC5/5/2026material
10-Q filing
SEC5/5/2026
8-K — Material agreement, Reg FD disclosure, Exhibits
SEC3/20/2026material
8-K — Shareholder vote results
SEC2/13/2026material
8-K — Results of operations, Exhibits
SEC2/5/2026material
10-Q filing
SEC2/5/2026

2025

8-K — Results of operations, Exhibits
SEC11/25/2025material
10-K filing
SEC11/25/2025
8-K — Executive/director change, Exhibits
SEC11/17/2025material
8-K — Results of operations, Exhibits
SEC8/8/2025material
10-Q filing
SEC8/8/2025

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.